Usana Health Sciences (USNA) Return on Capital Employed (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Return on Capital Employed data on file, last reported at 5.71% in Q2 2026.

• On a quarterly basis, Return on Capital Employed fell 368.0% year-over-year to 5.71% in Q2 2026; TTM through Apr 2026 was 5.71%, a 368.0% decrease from a year earlier, with the FY2026 full-year figure at 6.07%, down 597.0% from the prior year.
• Return on Capital Employed for Q2 2026 stood at 5.71%, down from 6.17% in the prior quarter.
• Over the last five years, Return on Capital Employed for USNA reached as high as 44.29% in Q1 2022 and fell as low as 5.71% in Q2 2026.
• Historically, Return on Capital Employed has averaged 21.02% across 5 years, with a median of 18.68% in 2023.
• Across the five-year window, Return on Capital Employed soared 519 bps in 2022 and slumped 2011 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 24.88% in 2022, then dropped by 25 bps to 18.68% in 2023, then plunged by 38 bps to 11.63% in 2024, then slipped by 19 bps to 9.4% in 2025, then sank by 39 bps to 5.71% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 5.71% in Q2 2026, 6.17% in Q1 2026, and 9.4% in Q1 2025.